Appetite & Weight Management

Peptides researched for appetite regulation, satiety signalling, and weight-management support. This goal page collects GLP-1 receptor agonists (semaglutide, liraglutide, exenatide), dual and triple incretin agonists (tirzepatide, retatrutide, cagrilintide), and emerging oral peptide alternatives (danuglipron, orforglipron) — spanning Phase III weight-loss trial data through to preclinical appetite-centre research.